Embedded Files
Learn about the degree of maturity in the implementation of good regulatory practices of pharmaceutical products according to the WHO in Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, and Peru.
Relive the launch of the Observatory of Good Regulatory Practices report and learn how Health Agencies are adopting WHO recommendations in the regulation of pharmaceutical products.
What is the purpose of the observatory?
What is the purpose of the observatory?
To provide a guide of Good Regulatory Practices in pharmaceutical products, which contributes to having strong regulatory systems, with leaders backed by an efficient framework of laws, regulations, and guides, based on the collection of information from different specialized actors on the subject.
To provide a guide of Good Regulatory Practices in pharmaceutical products, which contributes to having strong regulatory systems, with leaders backed by an efficient framework of laws, regulations, and guides, based on the collection of information from different specialized actors on the subject.
This study, is based on the Anexo 11 Buenas prácticas regulatorias en la regulación de productos médicos from the World Health Organization (WHO).
Learn more about Good Regulatory Practices:
Learn more about Good Regulatory Practices:
Measuring Regulatory Performance: A Practitioner’s Guide to Perception Surveys
OCDE: https://www.oecd.org/gov/regulatory-policy/LAC-Brochure-ESP.pdf
Live board
Live board
This study is an independent analysis of the adoption of Good Regulatory Practices (GPR) in the regulation of pharmaceutical products in eight (8) Latin American countries.
The information comes from reliable sources, however, the data and information described here will be subject to update and validation. This study is not an assessment of the maturity level of national drug regulatory authorities, nor does it substitute or replace official assessments conducted by authoritative bodies such as the World Health Organization (WHO) or the Pan American Health Organization (PAHO).
The findings are based on information available at the time of preparation and may be subject to change.
The study provides an overview of BPR in the countries analyzed and seeks to promote regulatory improvements.
The authors and the institution do not assume responsibility for decisions made based on this study.
The documents are copyrighted and non-commercial use is permitted with proper citation. By using these reports, you agree to the terms and conditions set forth in this legal notice and disclaimer.
Estudio elaborado por el Instituto de Prospectiva e Innovación en Salud (INNOS) en apoyo con FIFARMA
Page updated
Google Sites
Report abuse